Avera Pharmaceuticals   Report issue

For profit Phase 2
Founded: Carlsbad CA United States (2002)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
2005
NCT00235976
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Avera Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

av608 (3 trials)

gantacurium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 2)

Irritable Bowel Syndrome (Phase 1)

Phobia, Social (Phase 2)

Syndrome (Phase 1)

Urinary Bladder, Overactive (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2